Proleukin (aldesleukin)

News alerts, weekly reports and conference planners

Company:

Clinigen, Iovance Biotherap, Merck (MSD), Novartis, Roche

Drug class:

IL-2 stimulant, CD122 agonist

Related drugs:

›

No biomarker	Renal Cell Carcinoma	No biomarker	Renal Cell Carcinoma	aldesleukin Sensitive: A1 - Approval aldesleukin Sensitive : A1	aldesleukin Sensitive: A1 - Approval aldesleukin Sensitive : A1
No biomarker	Melanoma	No biomarker	Melanoma	aldesleukin Sensitive: A1 - Approval aldesleukin Sensitive : A1	aldesleukin Sensitive: A1 - Approval aldesleukin Sensitive : A1

Associations
(2)